Carotid Disease and CABG: What is the best Treatment

Size: px
Start display at page:

Download "Carotid Disease and CABG: What is the best Treatment"

Transcription

1 Carotid Disease and CABG: What is the best Treatment Dual Antiplatelets Luis A Guzman, MD, FACC, FSCAI Professor of Medicine Director, Cardiovascular Cath Lab Virginia Commonwealth University

2 Stroke during CABG. Main Causes Incidence 2% Low cardiac output Arrhythmias Oxygenation system Perfusion system Aortic arch Atherosclerosis Carotid stenosis

3 Stroke during CABG. Main Causes Incidence 2% Low cardiac output Arrhythmias Oxygenation system Perfusion system Aortic arch Atherosclerosis Carotid stenosis

4 Stroke Rate in Carotid Stenosis and CABG Carotid (-) Carotid (+) Carotid (-) Carotid >5 Bilateral Occlusion Stroke Stroke Brener et al. J Th Surg 1984 Naylor et al. Eur J Vasc Endovasc Surg. 23;26:23-41

5 Carotid Revascularization prior to CABG The guidelines by the AHA/ACC states that carotid endartherectomy is probably recommended before CABG or concomitant to CABG in patients with a symptomatic carotid stenosis or in asymptomatic patients with a unilateral or bilateral internal carotid stenosis of 8% or more (Indication IIa; Level of Evidence: C) AHA/ACC Guidelines. Circulation 26;113:1474

6 Carotid Revascularization prior to CABG Rational Strokes are associated with carotid stenosis CEA or CAS are indicated to decrease the incidence of stroke that would otherwise happen if carotid revascularization was not performed Where is the evidence?

7 Carotid Revascularization prior to CABG Rational Not a single randomized study exist today evaluating the hypothesis of stroke prevention for carotid revascularization prior to or during CABG In the USA there are +25, combined procedures/year

8 Carotid Revascularization prior to CABG Concerns and Flawed Many reports do not discriminate between symptomatic and asymptomatic Many report do not differentiate between unilateral, bilateral or occlusions Overestimation of event. Publication bias

9 Carotid Revascularization prior to CABG Concerns Among patients with stroke post CABG 5% had no Carotid disease 6% had disease in the opposite carotid Most strokes are in those with prior stroke but no carotid stenosis Overall, only 2% of the strokes were related to the ipsilateral carotid stenosis DeAgostino RS et al. Ann Thor Surgery 1996;82:1714

10 Carotid Revascularization prior to CABG Symptomatic Carotid Stenosis This is a different patient The associated CAD will change the risk profile but carotid revascularization should be performed first In very unusual situation with associated Unstable CAD, combined surgery could be considered

11 CEA and CABG Metaanalysis of 97 publications Combined Staged ,972 Asymptomatic Patients Stroke Death/Stroke Naylor et al. Eur J Vasc Endovasc Surg. 23;25:38-9

12 CEA and CABG Metaanalysis of 97 publications <1% of pts Combined Staged Carotid (-) Carotid >5 Bilateral Occlusion Stroke Death/Stroke Stroke Naylor et al. Eur J Vasc Endovasc Surg. 23;25:38-9

13 Stroke rate after CABG in Asymptomatic Severe Carotid Stenosis A Metaanalysis 2,531 pts All Symptomatic/Asymptomatic Patients Asymptomatic Patients 1 9, ,4 7, ,5 5, , > 5% > 7% > 8% > 5% > 7% Bilateral CEA/CABG Naylor AR et al. Eur J Vasc Endovasc 211,41:67-24

14 Stroke rate after CABG in Asymptomatic Bilateral Severe Carotid Stenosis with Combined Unilateral CEA: A Metaanalysis 22 pts 8 7 Contralateral Stroke 6, ,8 3,8 5,2 Bilat 5-99 Occlusion + >5% No CEA Bilat No CEA Occlusion Naylor AR et al. Eur J Vasc Endovasc 211,41:67-24

15 Carotid Stenting prior to CABG Possible Advantages of Stent over CEA No general anesthesia Less Invasive Antiplatelets therapy can be maintained Stroke rate? Mortality?

16

17 Carotid Stenting prior to CABG Systematic Analysis of 277 pts Major Events after Stent at Discharge Deaths 2 Fatal strokes 2 Cardiac deaths < Stroke > Stroke Death Death/Str

18 Carotid Stenting prior to CABG Systematic Analysis of 277 pts Major Events after Stent waiting for CABG < Stroke > Stroke Death Death/Str All 6 patients died due to a cardiac causes

19 Carotid Stenting prior to CABG Systematic Analysis of 277 pts 1 8 Major Events 3 days after CABG Stroke Death Death/Str

20 15 Carotid Stenting prior 21 Deaths to CABG 4 Fatal strokes 17 Cardiac deaths 2 post stent Systematic Analysis of 277 pts Overall Major Events 3 days after CABG 6 waiting for CABG 9 post CABG < Stroke > Stroke Death Death/>Str Death/Str

21 Simultaneous versus Delay CEA + CABG Randomized Study of Asymptomatic Patients with Unilateral Severe Carotid Stenosis: 9 Days Outcomes Simultaneous (n:94) Delay (n:91) 1 1,1 All Strokes occurred after CABG, before CEA Patients was aortic disease were excluded Overall Stroke: 4.5% D/Stroke: 4.9% Death Stroke D/Stroke 7 1 8,8 Illuminati G et al. J Vasc Surgery 211,54:993-9

22 Endovascular, Surgical or Hybrid for Patients with Combined Carotid and CAD The FRIENDS trail (n:659) 1 8 Predictors of Primary end point Endovascular: OR=.369; 95%CI= , p=.1 Hybrid: OR=3.98; 95%CI= , p=.7 8, ,25 4,8 2,4 All Surgery Endovascular Hybrid Ribichini F et al. Eurointervention 21,3:328-35

23 Endovascular, Surgical Combined or Surgical Staged for Patients with Associated Carotid and CAD. The CCF Registry (n:35) 3 Days Results P=.1 P=.1 Stent (n:11) 24 Most MI occurred while waiting for CABG in Staged group CAS delay to CABG mean 47 days CEA delay to CABG, mean 14 days P= Combined (n:195) Staged (n:45) 6 D/MI/Stroke Death Stroke MI 7 2 P= Shishehbor et al. JACC 213;62:

24 Endovascular, Surgical Combined or Surgical Staged for Patients with Associated Carotid and CAD. The CCF Registry (n:35) 1 Year Results P=.1 Combined (n:195) Staged (n:45) Stent (n:11) P= P= P=.6 8,7 6,7 D/MI/Stroke Death Stroke MI 1,8 1 3,6 Shishehbor et al. JACC 213;62:

25 Combined Carotid Endartherectomy and Off Pump CABG?

26 Carotid Revascularization prior to CABG High Risk Patients: Screening LMT Associated PAD Smoker 65 years Prior CVA/TIA Bilateral disease Chronic occlusion AHA/ACC Guidelines. Circulation 26;113:1474

27 Do We Need Carotid Screening in Asymptomatic Patients? Lin J et. J Vasc Surgery 216: 63:71-14

28 Outcomes post CABG According to Carotid Screening Carotid Screening (n:36) No Screening (n:1417) P=.27 4,3 P=.7 2,9 2,9 2,6 2 Death Stroke

29 Randomized Studies of CEA vs Medical management in CABG Patients with Asymptomatic stenosis. Does not include Stent arm. CABACS Trial Asymptomatic High Grade Carotid Stenosis CABG CABG + CEA N CABG + Stent Arm Int J Stroke, 7 (212), pp

30 Combined CAD and Carotid Stenosis Symptomatic Carotid Asymptomatic Carotid Asymptomatic CAD Symptomatic CAD Prior Stroke Severe Bilateral Dz Contralateral Occlusion Unilateral Stenosis No prior Strokes Carotid Revascularization CEA vs CAS CAD Treatment Combined Carotid (1 st ) and CABG CAS vs CEA According to anatomy No data (?) Higher risk group CABG alone probably as good as Combined CABG + Medical Management Unless prior stroke Carotid Screening is not required

31 Combined CAD and Carotid Stenosis Symptomatic Carotid Asymptomatic Carotid Asymptomatic CAD Symptomatic CAD Prior Stroke Severe Bilateral Dz Contralateral Occlusion Unilateral Stenosis No prior Strokes Carotid Revascularization CEA vs CAS CAD Treatment Combined Carotid (1 st ) and CABG CAS vs CEA According to anatomy No data (?) Higher risk group CABG alone probably as good as Combined Role of Carotid Stent? Role of Coronary stent? CABG + Medical Management Unless prior stroke Carotid Screening is not required

CardioLucca2014. Fare luce sulla scelta ottimale del trattamento nella rivascolarizzazione delle stenosi carotidee. Fabrizio Tomai

CardioLucca2014. Fare luce sulla scelta ottimale del trattamento nella rivascolarizzazione delle stenosi carotidee. Fabrizio Tomai CardioLucca2014 Fare luce sulla scelta ottimale del trattamento nella rivascolarizzazione delle stenosi carotidee Fabrizio Tomai European Hospital e Aurelia Hospital Roma Treatment of Carotid Artery Disease

More information

ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH

ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE IN PATIENTS WITH ACUTE CORONARY SYNDROME: INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH AUTHORS: Marta Ponte 1, RICARDO

More information

Prevention and Management of Cardiac Adverse Event

Prevention and Management of Cardiac Adverse Event Prevention and Management of Cardiac Adverse Event Carlo Cernetti Department of Interventional Cardiology Mirano (Italy) Cannes MEEC 14 June 2007 Are these risks factors of Haemodynamic Instability

More information

Management of combined coronary & carotid disease

Management of combined coronary & carotid disease Management of combined coronary & carotid disease Combined Carotid and coronary artery diseases Frequent combination Fear of imminent death psychologically traumatic for the patients and their families

More information

New Trials in Progress: ACT 1. Jon Matsumura, MD Cannes, France June 28, 2008

New Trials in Progress: ACT 1. Jon Matsumura, MD Cannes, France June 28, 2008 New Trials in Progress: ACT 1 Jon Matsumura, MD Cannes, France June 28, 2008 Faculty Disclosure I disclose the following financial relationships: Consultant, CAS training director, and/or research grants

More information

CAROTID STENTING A 2009 UPDATE. Hoang Duong, MD Director of Interventional Neuroradiology Memorial Regional Hospital

CAROTID STENTING A 2009 UPDATE. Hoang Duong, MD Director of Interventional Neuroradiology Memorial Regional Hospital CAROTID STENTING A 2009 UPDATE Hoang Duong, MD Director of Interventional Neuroradiology Memorial Regional Hospital TREATMENT FOR CAROTID STENOSIS Best medical management Antiplatelet therapy Antihypertensive

More information

Open heart surgery or carotid endarterectomy. Which procedure should be done first?

Open heart surgery or carotid endarterectomy. Which procedure should be done first? Open heart surgery or carotid endarterectomy. Which procedure should be done first? Pedro Pinto Sousa 1, Gabriela Teixeira 2, João Gonçalves 2 ; Luís Vouga 1, Rui Almeida 2 ; Pedro Sá Pinto 2 1 Centro

More information

Fast-track CEA: a 3-year experience

Fast-track CEA: a 3-year experience Fast-track CEA: a 3-year experience Giorgio L. Poletto, MD Milano, Italy 6th ACST-2 Collaborators Meeting, Palau de Congresos, Valencia. 24th and 25th September 2018. Stroke prevention Primary prevention:

More information

Non-Selective Carotid Artery Ultrasound Screening in Patients Undergoing Coronary Artery Bypass Grafting: Is It Necessary?

Non-Selective Carotid Artery Ultrasound Screening in Patients Undergoing Coronary Artery Bypass Grafting: Is It Necessary? Non-Selective Carotid Artery Ultrasound Screening in Patients Undergoing Coronary Artery Bypass Grafting: Is It Necessary? Khalil Masabni, Joseph F. Sabik III, Sajjad Raza, Theresa Carnes, Hemantha Koduri,

More information

TAVR y Enfermedad Coronaria. Mauricio G. Cohen, MD, FACC, FSCAI Director, Cardiac Catheterization Lab Associate Professor of Medicine

TAVR y Enfermedad Coronaria. Mauricio G. Cohen, MD, FACC, FSCAI Director, Cardiac Catheterization Lab Associate Professor of Medicine TAVR y Enfermedad Coronaria Mauricio G. Cohen, MD, FACC, FSCAI Director, Cardiac Catheterization Lab Associate Professor of Medicine CAD and AS Similar Pathological Processes CAD in TAVR Patients (n=390)

More information

Carotid Artery Stent: Is it ready for prime time?

Carotid Artery Stent: Is it ready for prime time? 2010 CATH LAB SYMPOSIUM Carotid Artery Stent: Is it ready for prime time? Luis F. Tami, MD, FACC, FSCAI Interventional Cardiology and Vascular Medicine Memorial Regional Hospital August 2010 CAE and CAS

More information

Peter A. Soukas, M.D., FACC, FSVM, FSCAI, RPVI

Peter A. Soukas, M.D., FACC, FSVM, FSCAI, RPVI Peter A. Soukas, M.D., FACC, FSVM, FSCAI, RPVI Director, Peripheral Vascular Interventional Laboratory Director, Vascular & Endovascular Medicine Fellowship Program Assistant Professor of Medicine The

More information

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology Cardiac evaluation for the noncardiac patient Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology Objectives! Review ACC / AHA guidelines as updated for 2009! Discuss new recommendations

More information

Surgery for patients with diffuse atherosclerotic disease

Surgery for patients with diffuse atherosclerotic disease Surgery for patients with diffuse atherosclerotic disease Special hospital for surgery Skopje Macedonia September, 2012 Mitrev Z, Anguseva T, E.Stoicovski, Hristov N, E.Idoski Oktomvri, 2008 Atherosclerosis

More information

I have the following potential conflicts of interest to report. honorarium: 1. St Jude Medical 2. Biotronik 3. Boston Scientific

I have the following potential conflicts of interest to report. honorarium: 1. St Jude Medical 2. Biotronik 3. Boston Scientific Stenting carotideo nel paziente sintomatico alla luce dei nuovi trials Savona, 11 Aprile 2015 Gioel GabrioSecco, MD, PhD Emodinamica e CardiologiaInterventistica Ospedale SantiAntonio e Biagio e Cesare

More information

A new era in the treatment of peripheral artery disease (PAD)?

A new era in the treatment of peripheral artery disease (PAD)? A new era in the treatment of peripheral artery disease (PAD)? Prof. Dr. Jan Beyer-Westendorf Head of Thrombosis Research, University Hospital Carl Gustav Carus, TU Dresden; Germany Senior Lecturer Thrombosis

More information

DCB use in fem-pop lesions of patients with CLI (RCC 4-5): subgroup analysis of IN.PACT Global 12-month outcomes

DCB use in fem-pop lesions of patients with CLI (RCC 4-5): subgroup analysis of IN.PACT Global 12-month outcomes DCB use in fem-pop lesions of patients with CLI (RCC 4-5): subgroup analysis of IN.PACT Global 12-month outcomes Carlos Mena, MD FACC FSCAI Associate Professor of Medicine - Cardiology Director Cardiac

More information

Perioperative Cardiology Consultations for Noncardiac Surgery Ischemic Heart Disease

Perioperative Cardiology Consultations for Noncardiac Surgery Ischemic Heart Disease 2012 대한춘계심장학회 Perioperative Cardiology Consultations for Noncardiac Surgery Ischemic Heart Disease 울산의대울산대학병원심장내과이상곤 ECG CLASS IIb 1. Preoperative resting 12-lead ECG may be reasonable in patients with

More information

03/30/2016 DISCLOSURES TO OPERATE OR NOT THAT IS THE QUESTION CAROTID INTERVENTION IS INDICATED FOR ASYMPTOMATIC CAROTID OCCLUSIVE DISEASE

03/30/2016 DISCLOSURES TO OPERATE OR NOT THAT IS THE QUESTION CAROTID INTERVENTION IS INDICATED FOR ASYMPTOMATIC CAROTID OCCLUSIVE DISEASE CAROTID INTERVENTION IS INDICATED FOR ASYMPTOMATIC CAROTID OCCLUSIVE DISEASE Elizabeth L. Detschelt, M.D. Allegheny Health Network Vascular and Endovascular Symposium April 2, 2016 DISCLOSURES I have no

More information

The Great Swedish Debate. Håkan Pärsson Department Vascular Surgery Helsingborgs Lasarett, University Lund

The Great Swedish Debate. Håkan Pärsson Department Vascular Surgery Helsingborgs Lasarett, University Lund The Great Swedish Debate Håkan Pärsson Department Vascular Surgery Helsingborgs Lasarett, University Lund My Disclosures Trying to bribe the moderators What do my patients expect? Balanced information

More information

Surgery Grand Rounds

Surgery Grand Rounds Surgery Grand Rounds Coronary Artery Bypass Grafting versus Coronary Artery Stenting Charles Ted Lord, R1 Coronary Artery Disease Stenosis of epicardial vessels Metabolic & hematologic Statistics 500,000

More information

Carotid Endarterectomy vs. Carotid artery Stenting (Surgeon Perspective)

Carotid Endarterectomy vs. Carotid artery Stenting (Surgeon Perspective) Carotid Endarterectomy vs. Carotid artery Stenting (Surgeon Perspective) T-Woei Tan, MD, FACS, RPVI Assistant Professor of Surgery Vascular and Endovascular Surgery Louisiana State University Health -

More information

Carotid Artery Disease How the Data Will Influence Management The Symptomatic vs. the Asymptomatic Patient

Carotid Artery Disease How the Data Will Influence Management The Symptomatic vs. the Asymptomatic Patient Carotid Artery Disease How the 2014-2015 Data Will Influence Management The Symptomatic vs. the Asymptomatic Patient Christopher J. White, MD, MSCAI, FACC, FAHA, FESC Professor and Chair of Medicine Ochsner

More information

My Latest Take on RCT Data: When is CEA or CAS the Best Option? The Interventional Position

My Latest Take on RCT Data: When is CEA or CAS the Best Option? The Interventional Position LINC 2016 Leipzig, Jan 26-29, 2016 My Latest Take on RCT Data: When is CEA or CAS the Best Option? The Interventional Position Horst Sievert, Iris Grunwald CardioVasculäres Centrum Frankfurt - CVC, Frankfurt

More information

DESCRIPTION: Percent of asymptomatic patients undergoing CEA who are discharged to home no later than post-operative day #2

DESCRIPTION: Percent of asymptomatic patients undergoing CEA who are discharged to home no later than post-operative day #2 Measure #260: Rate of Carotid Endarterectomy (CEA) for Asymptomatic Patients, without Major Complications (Discharged to Home by Post-Operative Day #2) National Quality Strategy Domain: Patient Safety

More information

MEET Θ symptomatic patients. K. Mathias Department of Radiology Teaching Hospital of Dortmund - Germany

MEET Θ symptomatic patients. K. Mathias Department of Radiology Teaching Hospital of Dortmund - Germany MEET Θ 2006 Why I stent asymptomatic and symptomatic patients K. Mathias Department of Radiology Teaching Hospital of Dortmund - Germany Evidence for treating symptomatic patients symptomatic patients

More information

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY Measure #260: Rate of Carotid Endarterectomy (CEA) for Asymptomatic Patients, without Major Complications (Discharged to Home by Post-Operative Day #2) National Quality Strategy Domain: Patient Safety

More information

Controversies in Cardiac Pharmacology

Controversies in Cardiac Pharmacology Controversies in Cardiac Pharmacology Thomas D. Conley, MD FACC FSCAI Disclosures I have no relevant relationships with commercial interests to disclose. 1 Doc, do I really need to take all these medicines?

More information

Hidden coronary disease in carotid patients

Hidden coronary disease in carotid patients 6 th ACST-2 Collaborators Meeting in Valencia, Spain 24th and 25th September 2018 Hidden coronary disease in carotid patients Valerio Tolva Policlinico di Monza Italy Are we always aware of coronary anatomy?

More information

Cardiac Perioperative Risk Assessment American Heart Association Guidelines

Cardiac Perioperative Risk Assessment American Heart Association Guidelines Cardiac Perioperative Risk Assessment American Heart Association Guidelines Dr Gary Liew, MBBS, PhD, FRACP US Board Certified in Cardiovascular CT Executive Committee, Cardiac Institute, Epworth Healthcare

More information

Carotid Artery Stenting

Carotid Artery Stenting Carotid Artery Stenting Woong Chol Kang M.D. Gil Medical Center, Gachon University of Medicine and Science, Incheon, Korea Carotid Stenosis and Stroke ~25% of stroke is due to carotid disease, the reminder

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome Quality ID #345 (NQF 1543): Rate of Asymptomatic Patients Undergoing Carotid Artery Stenting (CAS) Who Are Stroke Free or Discharged Alive National Quality Strategy Domain: Effective Clinical Care 2018

More information

Stroke prevention in asymptomatic carotid stenosis. ΛΙΛΛΗΣ ΛΕΩΝΙΔΑΣ Καρδιολόγος Επιστημονικός Συνεργάτης Α Καρδιολογικής Κλινικής ΑΠΘ ΠΓΝΘ ΑΧΕΠΑ

Stroke prevention in asymptomatic carotid stenosis. ΛΙΛΛΗΣ ΛΕΩΝΙΔΑΣ Καρδιολόγος Επιστημονικός Συνεργάτης Α Καρδιολογικής Κλινικής ΑΠΘ ΠΓΝΘ ΑΧΕΠΑ Stroke prevention in asymptomatic carotid stenosis ΛΙΛΛΗΣ ΛΕΩΝΙΔΑΣ Καρδιολόγος Επιστημονικός Συνεργάτης Α Καρδιολογικής Κλινικής ΑΠΘ ΠΓΝΘ ΑΧΕΠΑ Σεμινάρια Ομάδων Εργασίας Ελληνικής Καρδιολογικής Εταιρείας

More information

Update : Carotid Stenting and Current Trial Data

Update : Carotid Stenting and Current Trial Data Update : Carotid Stenting and Current Trial Data J. Michael Bacharach, MD, MPH, FACC, FSCAI Section Head, Vascular Medicine and Vascular Intervention North Central Heart Institute, Sioux Falls, South Dakota

More information

Hybrid surgical treatment of bilateral aorto-femoral occlusion: a clinical case

Hybrid surgical treatment of bilateral aorto-femoral occlusion: a clinical case Hybrid surgical treatment of bilateral aorto-femoral occlusion: a clinical case Chernyavskiy M.,MD,PhD, Chernova D., Zherdev N., Chernov A. Almazov National Medical Research Centre, St.Petersburg, Russia

More information

Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines

Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines Enrico Ferrari, MD Cardiac Surgery Unit Cardiocentro Ticino Foundation Lugano, Switzerland Conflict of Interests No conflict

More information

TCAR: TransCarotid Artery Revascularization Angela A. Kokkosis, MD, RPVI, FACS

TCAR: TransCarotid Artery Revascularization Angela A. Kokkosis, MD, RPVI, FACS TCAR: TransCarotid Artery Revascularization Angela A. Kokkosis, MD, RPVI, FACS Assistant Professor of Surgery Director of Carotid Interventions Division of Vascular & Endovascular Surgery Stony Brook University

More information

Introduction to Peripheral Arterial Disease. Stacey Clegg, MD Interventional Cardiology August

Introduction to Peripheral Arterial Disease. Stacey Clegg, MD Interventional Cardiology August Introduction to Peripheral Arterial Disease Stacey Clegg, MD Interventional Cardiology August 20 2014 Outline (and for the ABIM board exam * ** ***) Prevalence* Definitions Lower Extremity: Aorta*** Claudication***

More information

Simultaneous Acute ST Elevation Myocardial Infarction And Acute Left Subclavian Artery Thrombosis

Simultaneous Acute ST Elevation Myocardial Infarction And Acute Left Subclavian Artery Thrombosis Simultaneous Acute ST Elevation Myocardial Infarction And Acute Left Subclavian Artery Thrombosis Chee Yang CHIN, MBChB, MRCP(UK) C.W.L. Chin, P.T.L. Chiam, R.S. Tan National Heart Centre Singapore 26

More information

Carotid stenosis management: CAS or CEA? Yaoguo Yang, Chen Zhong Beijing Anzhen Hospital,China

Carotid stenosis management: CAS or CEA? Yaoguo Yang, Chen Zhong Beijing Anzhen Hospital,China Carotid stenosis management: CAS or CEA? Yaoguo Yang, Chen Zhong Beijing Anzhen Hospital,China Disclosure Speaker name:... I have the following potential conflicts of interest to report: Consulting Employment

More information

Optimal testing for coronary artery disease in symptomatic and asymptomatic patients

Optimal testing for coronary artery disease in symptomatic and asymptomatic patients Optimal testing for coronary artery disease in symptomatic and asymptomatic patients Alexandre C Ferreira, MD Clinical Chief of Cardiology Jackson Health System Director, Interventional Cardiology Training

More information

Carotid Artery Stenosis

Carotid Artery Stenosis Evidence-Based Approach to Carotid Artery Stenosis Seong-Wook Park, MD Division of Cardiology, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea Carotid Artery Stenosis Carotid

More information

Carotid Artery Stenting Today: A Few Updating Remarks

Carotid Artery Stenting Today: A Few Updating Remarks Carotid Artery Stenting Today: A Few Updating Remarks Camilo R. Gomez, MD, MBA Director, Alabama Neurological Institute Birmingham, Alabama Disclaimer & Warning Company Pharmaceutical BMS-Sanofi-Aventis

More information

Diabetes and Occult Coronary Artery Disease

Diabetes and Occult Coronary Artery Disease Diabetes and Occult Coronary Artery Disease Mun K. Hong, MD, FACC, FSCAI Director, Cardiac Catheterization Laboratory & Interventional Cardiology St. Luke s-roosevelt Hospital Center New York, New York

More information

Carotid Artery Revascularization: Current Strategies. Shonda Banegas, D.O. Vascular Surgery Carondelet Heart and Vascular Institute September 6, 2014

Carotid Artery Revascularization: Current Strategies. Shonda Banegas, D.O. Vascular Surgery Carondelet Heart and Vascular Institute September 6, 2014 Carotid Artery Revascularization: Current Strategies Shonda Banegas, D.O. Vascular Surgery Carondelet Heart and Vascular Institute September 6, 2014 Disclosures None 1 Stroke in 2014 Stroke kills almost

More information

Quando rivascolarizzare il paziente anziano con stenosi coronariche paucisintomatiche

Quando rivascolarizzare il paziente anziano con stenosi coronariche paucisintomatiche Quando rivascolarizzare il paziente anziano con stenosi coronariche paucisintomatiche Fabrizio Tomai, MD, FCC, FESC Dept. Cardiovascular Sciences Interventional Cardiology Unit European Hospital - urelia

More information

Tips and Tricks for CAS T-CAR

Tips and Tricks for CAS T-CAR Tips and Tricks for CAS T-CAR H.-H. Eckstein, M. Kallmayer Department for Vascular and Endovascular Surgery, Klinikum Rechts der Isar, Technical University of Munich,, Germany Disclosures Collaborator

More information

Medical Therapy for Peripheral Artery Disease

Medical Therapy for Peripheral Artery Disease Medical Therapy for Peripheral Artery Disease Beau M. Hawkins, MD, FSCAI University of Oklahoma Health Sciences Center, Oklahoma City, OK Sahil A. Parikh, MD, FSCAI Columbia University Medical Center,

More information

Disclosures. State of the Art Management of Carotid Stenosis. NIH funding for clinical trials Consultant for Scientia Vascular and Medtronic

Disclosures. State of the Art Management of Carotid Stenosis. NIH funding for clinical trials Consultant for Scientia Vascular and Medtronic State of the Art Management of Carotid Stenosis Mark R. Harrigan, MD UAB Stroke Center Professor of Neurosurgery, Neurology, and Radiology University of Alabama, Birmingham Disclosures NIH funding for

More information

Clinical trial and real-world outcomes of an endovascular iliac aneurysm repair with the GORE Iliac Branch Endoprosthesis (IBE)

Clinical trial and real-world outcomes of an endovascular iliac aneurysm repair with the GORE Iliac Branch Endoprosthesis (IBE) Clinical trial and real-world outcomes of an endovascular iliac aneurysm repair with the GORE Iliac Branch Endoprosthesis (IBE) Jan MM Heyligers, PhD, FEBVS Consultant Vascular Surgeon The Netherlands

More information

Update on the only remaining Carotid Multicenter Randomised International Trial in the World:ACST-2

Update on the only remaining Carotid Multicenter Randomised International Trial in the World:ACST-2 Update on the only remaining Carotid Multicenter Randomised International Trial in the World:ACST-2 Alison Halliday MD Professor of Vascular Surgery University of Oxford Disclosure Statement of Financial

More information

BULgarian Carotid Artery Stenting versus Surgery Study (BULCASSS): Randomized single center trial

BULgarian Carotid Artery Stenting versus Surgery Study (BULCASSS): Randomized single center trial BULgarian Carotid Artery Stenting versus Surgery Study (): Randomized single center trial Ivo Petrov, M. Konteva, H. Dimitrov, K. Kichukov Tokuda Hospital Sofia Cardiology Department Background Carotid

More information

Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO

Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO Goal of treatment of carotid disease Identify those at risk of developing symptoms Prevent patients at risk from developing symptoms Prevent

More information

Long-Term Outcomes of Synchronous Carotid Endarterectomy and Coronary Artery Bypass Grafting versus Solely Carotid Endarterectomy

Long-Term Outcomes of Synchronous Carotid Endarterectomy and Coronary Artery Bypass Grafting versus Solely Carotid Endarterectomy Ann Thorac Cardiovasc Surg 2012; 18: 228 235 doi: 10.5761/atcs.oa.12.01928 Original Article Long-Term Outcomes of Synchronous Carotid Endarterectomy and Coronary Artery Bypass Grafting versus Solely Carotid

More information

Larry Diaz, MD, FSCAI Mehdi H. Shishehbor, DO, FSCAI

Larry Diaz, MD, FSCAI Mehdi H. Shishehbor, DO, FSCAI PAD Diagnosis Larry Diaz, MD, FSCAI Metro Health / University of Michigan Health, Wyoming, MI Mehdi H. Shishehbor, DO, FSCAI University Hospitals Harrington Heart & Vascular Institute, Cleveland, OH PAD:

More information

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Mun K. Hong, MD Associate Professor of Medicine Director, Cardiovascular Intervention and Research Weill Cornell

More information

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome Measure #344: Rate of Carotid Artery Stenting (CAS) for Asymptomatic Patients, Without Major Complications (Discharged to Home by Post-Operative Day #2) National Quality Strategy Domain: Effective Clinical

More information

- Lecture - Recommandations ESC : messages importants P. MEYER (Saint Laurent du Var) - Controverse - Qui doit faire l'angioplastie périphérique?

- Lecture - Recommandations ESC : messages importants P. MEYER (Saint Laurent du Var) - Controverse - Qui doit faire l'angioplastie périphérique? - Lecture - Recommandations ESC : messages importants P. MEYER (Saint Laurent du Var) - Controverse - Qui doit faire l'angioplastie périphérique? Un chirurgien E. DUCASSE (Bordeaux) Un interventionnel

More information

Disclosures. CREST Trial: Summary. Lecture Outline 4/16/2015. Cervical Atherosclerotic Disease

Disclosures. CREST Trial: Summary. Lecture Outline 4/16/2015. Cervical Atherosclerotic Disease Disclosures Your Patient Has Carotid Bulb Stenosis and a Tandem Intracranial Stenosis: How Do SAMMPRIS and Other Evidence Inform Your Treatment? UCSF Vascular Symposium 2015 Steven W. Hetts, MD Associate

More information

Carotid Artery Stenting Versus

Carotid Artery Stenting Versus Carotid Artery Stenting Versus Carotid Endarterectomy Seong-Wook Park, MD, PhD, FACC,, Seoul, Korea Stroke & Carotid artery stenosis Stroke & Carotid artery stenosis Cerebrovascular disease is one of the

More information

Registry Assessment of Peripheral Interventional Devices (RAPID)

Registry Assessment of Peripheral Interventional Devices (RAPID) Registry Assessment of Peripheral Interventional Devices (RAPID) Adding Data Sources May 2, 2018 W. Schuyler Jones, MD Duke Clinical Research Institute Duke Heart Center Disclosures Research Grants: Agency

More information

For Personal Use. Copyright HMP 2013

For Personal Use. Copyright HMP 2013 Original Contribution Staged Carotid Artery Stenting and Coronary Artery Bypass Surgery Versus Isolated Coronary Artery Bypass Surgery in Concomitant Coronary and Carotid Disease Seyed Ebrahim Kassaian,

More information

Clinical Considerations for CTO

Clinical Considerations for CTO 38 RCTs Clinical Considerations for CTO 18,000 pts Revascularization Whom to treat, Who derives benefit and What can we achieve? David E. Kandzari, MD FACC, FSCAI Director, Interventional Cardiology Research

More information

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO!

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO! Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO! Young-Hak Kim, MD, PhD Heart Institute, University of Ulsan College of Medicine Asan Medical Center,

More information

Predictors of restenosis and cardiovascular events in patients undergoing percutaneous angioplasty for subclavian/innominate artery stenosis

Predictors of restenosis and cardiovascular events in patients undergoing percutaneous angioplasty for subclavian/innominate artery stenosis Predictors of restenosis and cardiovascular events in patients undergoing percutaneous angioplasty for subclavian/innominate artery stenosis Tadeusz Przewlocki, Anna Kablak Ziembicka, Piotr Pieniazek,

More information

Diagnostic, Technical and Medical

Diagnostic, Technical and Medical Diagnostic, Technical and Medical Approaches to Reduce CABG Related Stroke Pieter Kappetein, Michael Mack, M.D. Dept Thoracic Surgery, Rotterdam, The Netherlands Baylor Healthcare System Dallas, TX Background

More information

Contemporary Management of Carotid Disease What We Know So Far

Contemporary Management of Carotid Disease What We Know So Far Contemporary Management of Carotid Disease What We Know So Far Ammar Safar, MD, FSCAI, FACC, FACP, RPVI Interventional Cardiology & Endovascular Medicine Disclosers NONE Epidemiology 80 % of stroke are

More information

Impact of the Aortic Arch on Stent Performance

Impact of the Aortic Arch on Stent Performance Impact of the Aortic Arch on Stent Performance GianLuca Faggioli Vascular Surgery Alma Mater Studiorum UniversitY of Bologna ACST-2 Indications for carotid stenting: a preview of the potential derived

More information

Current Role of Renal Artery Stenting in Patients with Renal Artery Stenosis

Current Role of Renal Artery Stenting in Patients with Renal Artery Stenosis Current Role of Renal Artery Stenting in Patients with Renal Artery Stenosis Young-Guk Ko, M.D. Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea Etiology Fibromuscular

More information

PAD Characterization Within A Healthcare System" RAPID Face-to-Face Meeting Schuyler Jones, MD September 14, 2016

PAD Characterization Within A Healthcare System RAPID Face-to-Face Meeting Schuyler Jones, MD September 14, 2016 PAD Characterization Within A Healthcare System" RAPID Face-to-Face Meeting Schuyler, MD September 14, 2016 Interventional Cardiology and Cath Labs Disclosures Research Grants: Agency for Healthcare Research

More information

UPMC HAMOT CAROTID ARTERY DISEASE WHERE DO WE GO FROM HERE?

UPMC HAMOT CAROTID ARTERY DISEASE WHERE DO WE GO FROM HERE? UPMC HAMOT CAROTID ARTERY DISEASE WHERE DO WE GO FROM HERE? Richard W. Petrella M.D. FACP,FACC,FASCI DEPARTMENT CHAIRMAN CVM&S UPMC HAMOT MEDICAL CENTER 1 LEARNING OBJECTIVES REVIEW THE RISK FACTORS FOR

More information

How to Choose Between Carotid Stenting and Carotid Endarterectomy for Stroke Prevention

How to Choose Between Carotid Stenting and Carotid Endarterectomy for Stroke Prevention How to Choose Between Carotid Stenting and Carotid Endarterectomy for Stroke Prevention Christopher J. White MD, MSCAI Chief of Medical Services, Professor and Chairman of Medicine Ochsner Medical Center

More information

Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine

Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine Institute The Oregon Clinic Disclosure I declare that neither

More information

Alma Mater Studiorum Università di Bologna

Alma Mater Studiorum Università di Bologna Alma Mater Studiorum Università di Bologna S.Orsola-Malpighi, Bologna, Italia Chirurgia Vascolare The volume of cerebral ischaemic lesion predicts the outcome after symptomatic carotid revascularisation

More information

Severe Aortic Valve Disease: TAVR in Four Ages and Four Etiologies Age 25 y/o Congenital, 50 y/o Bicuspid, 75 y/o Rheumatic, 100 y/o Degenerative

Severe Aortic Valve Disease: TAVR in Four Ages and Four Etiologies Age 25 y/o Congenital, 50 y/o Bicuspid, 75 y/o Rheumatic, 100 y/o Degenerative Severe Aortic Valve Disease: TAVR in Four Ages and Four Etiologies Age 25 y/o Congenital, 50 y/o Bicuspid, 75 y/o Rheumatic, 100 y/o Degenerative Samin K. Sharma, MD, FACC, FSCAI Director Clinical & Interventional

More information

OBJECTIVES. New Twist To Old Disease: Cardiovascular Update /9/2017. Prevention Pre-operative Coronary Artery Disease

OBJECTIVES. New Twist To Old Disease: Cardiovascular Update /9/2017. Prevention Pre-operative Coronary Artery Disease New Twist To Old Disease: Cardiovascular Update 2017 Sridevi R Pitta, M.D.,MBA, F.S.C.A.I., R.P.V.I Medical Director for STEMI, Medical Director for CV Quality Council, Interventional Cardiologist & Endovascular

More information

ESC Heart & Brain Workshop

ESC Heart & Brain Workshop ESC Heart & Brain Workshop The role of vascular surgeon in stroke prevention Barbara Rantner, MD, PhD, Department of Vascular Surgery, Medical University Innsbruck, Innsbruck, Austria Supported by Bayer,

More information

8/28/2018. Pre-op Evaluation for non cardiac surgery. A quick review from 2007!! Disclosures. John Steuter, MD. None

8/28/2018. Pre-op Evaluation for non cardiac surgery. A quick review from 2007!! Disclosures. John Steuter, MD. None Pre-op Evaluation for non cardiac surgery John Steuter, MD Disclosures None A quick review from 2007!! Fliesheret al, ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and are for Noncardiac

More information

Carotid Ddisease, Carotid IMT and Risk of Stroke

Carotid Ddisease, Carotid IMT and Risk of Stroke Carotid Ddisease, Carotid IMT and Risk of Stroke TATJANA RUNDEK, MD PhD Professor of Neurology, Epidemiology and Public Health Director, Clinical translational Division Department of Neurology, Miller

More information

Surgical Treatment of Carotid Disease

Surgical Treatment of Carotid Disease Department of Cardiothoracic & Vascular Surgery McGovern Medical School / The University of Texas Health Science Center at Houston Surgical Treatment of Carotid Disease The Old, the New, and the Future

More information

Final Clinical and Angiographic Results From a Nationwide Registry of FIREBIRD Sirolimus- Eluting Stent: Firebird In China (FIC) Registry (PI R. Gao)

Final Clinical and Angiographic Results From a Nationwide Registry of FIREBIRD Sirolimus- Eluting Stent: Firebird In China (FIC) Registry (PI R. Gao) The Microport FIREBIRD Polymer-based Sirolimus- Eluting Stent Clinical Trial Program Update: The FIC and FIREMAN Registries Junbo Ge, MD, FACC, FESC, FSCAI On behalf of Runlin Gao (FIC PI) and Haichang

More information

Carotid Revascularization

Carotid Revascularization Options for Carotid Disease Carotid Revascularization Wayne Causey, MD 2 nd Year Vascular Surgery Fellow Best medical therapy, Carotid Endarterectomy, and Carotid Stenting Who benefits from best medical

More information

Post-op Carotid Complications A Nursing Perspective of What to Watch Out for

Post-op Carotid Complications A Nursing Perspective of What to Watch Out for Post-op Carotid Complications A Nursing Perspective of What to Watch Out for By Kariss Peterson, ARNP Swedish Medical Center Inpatient Neurology Team 1 Post-op Carotid Management Objectives Review the

More information

Joshua A. Beckman, MD. Brigham and Women s Hospital

Joshua A. Beckman, MD. Brigham and Women s Hospital Peripheral Vascular Disease: Overview, Peripheral Arterial Obstructive Disease, Carotid Artery Disease, and Renovascular Disease as a Surrogate for Coronary Artery Disease Joshua A. Beckman, MD Brigham

More information

PCIs on Intermediate Lesions NCDR Cath-PCI Registry

PCIs on Intermediate Lesions NCDR Cath-PCI Registry Practical Application Of Coronary Physiology in The Cath Lab Talal T Attar, MD, MBA, FACC PCIs on Intermediate Lesions NCDR Cath-PCI Registry Fraction of stenoses 50-70% treated with PCI without further

More information

Evolving Challenges in the Evaluation and Treatment of Lower Extremity PAD -- The Peripheral Academic Research Consortium (PARC)

Evolving Challenges in the Evaluation and Treatment of Lower Extremity PAD -- The Peripheral Academic Research Consortium (PARC) Evolving Challenges in the Evaluation and Treatment of Lower Extremity PAD -- The Peripheral Academic Research Consortium (PARC) W. Schuyler Jones, MD FACC Director, Adult Cardiac Catheterization Laboratory

More information

Review of clinical carotid stent procedural & long-term outcomes in. symptomatic asymptomatic. patients

Review of clinical carotid stent procedural & long-term outcomes in. symptomatic asymptomatic. patients Review of clinical carotid stent procedural & long-term outcomes in symptomatic asymptomatic patients 1 Conflict of Interest Statement Within the past 12 months, I or my spouse have had a financial interest/arrangement

More information

The PARADIGM Study. Jagiellonian University Dept. of Cardiac & Vascular Diseases. John Paul II Hospital, Krakow, Poland

The PARADIGM Study. Jagiellonian University Dept. of Cardiac & Vascular Diseases. John Paul II Hospital, Krakow, Poland Prospective evaluation of All-comer percutaneous carotid revascularization In symptomatic and increased-risk asymptomatic carotid artery stenosis using CGuard Micronet-covered embolic prevention stent

More information

Endovascular and Hybrid Treatment of TASC C & D Aortoiliac Occlusive Disease

Endovascular and Hybrid Treatment of TASC C & D Aortoiliac Occlusive Disease Endovascular and Hybrid Treatment of TASC C & D Aortoiliac Occlusive Disease Arash Bornak, MD FACS Vascular & Endovascular Surgery University of Miami Miller School of Medicine No disclosure BACKGROUND

More information

DESPITE CURRENT LEVEL 1 EVIDENCE THE OUTLOOK FOR AN UPSURGE IN CAROTID STENTING (CAS) IS BRIGHT FRANK J. VEITH LINC LEIPZIG JANUARY 27, 2015

DESPITE CURRENT LEVEL 1 EVIDENCE THE OUTLOOK FOR AN UPSURGE IN CAROTID STENTING (CAS) IS BRIGHT FRANK J. VEITH LINC LEIPZIG JANUARY 27, 2015 DESPITE CURRENT LEVEL 1 EVIDENCE THE OUTLOOK FOR AN UPSURGE IN CAROTID STENTING (CAS) IS BRIGHT FRANK J. VEITH LINC - 2015 LEIPZIG JANUARY 27, 2015 Disclosure Speaker name: FRANK J. VEITH DESPITE SOME

More information

Endovascular vs Surgical Carotid Revascularisation

Endovascular vs Surgical Carotid Revascularisation Endovascular vs Surgical Carotid Revascularisation Lessons Learned from Clinical Trials and How I Approach it in My Practice Ramon L. Varcoe, MBBS, MS, FRACS, PhD Associate Professor of Vascular Surgery

More information

Peripheral Arterial Disease: Who has it and what to do about it?

Peripheral Arterial Disease: Who has it and what to do about it? Peripheral Arterial Disease: Who has it and what to do about it? Seth Krauss, M.D. Alaska Annual Nurse Practitioner Conference September 16, 2011 Scope of the Problem Incidence: 20%

More information

TIA SINGOLO E IN CRESCENDO: due diversi scenari della rivascolarizzazione urgente carotidea

TIA SINGOLO E IN CRESCENDO: due diversi scenari della rivascolarizzazione urgente carotidea TIA SINGOLO E IN CRESCENDO: due diversi scenari della rivascolarizzazione urgente carotidea R. Pini, G.L. Faggioli, M. Gargiulo, E. Pisano, A. Pilato, E. Gallitto, C. Mascoli, L.M. Cacioppa, A. Vacirca,

More information

Upgrade of Recommendation

Upgrade of Recommendation Challenges in LM PCI Decision-making process for stenting Young-Hak Kim, MD, PhD, Heart Institute, University of Ulsan College of Medicine Asan Medical Center, Seoul, Korea Upgrade of Recommendation for

More information

FFR-CT Not Ready for Primetime

FFR-CT Not Ready for Primetime FFR-CT Not Ready for Primetime Leslee J. Shaw, PhD, MASNC, FACC, FAHA, FSCCT R. Bruce Logue Professor of Medicine Co-Director, Emory Clinical CV Research Institute Emory University School of Medicine Atlanta,

More information

Internal carotid artery near-total occlusions: Is it justified to operate on them?

Internal carotid artery near-total occlusions: Is it justified to operate on them? Internal carotid artery near-total occlusions: Is it justified to operate on them? Christos D. Liapis Professor (Em) of Vascular Surgery Athens University Medical School Director Vascular & Endovascular

More information

William A. Gray MD System Chief of Cardiovascular Services, Main Line Health President, Lankenau Heart Institute Wynnewood, PA USA

William A. Gray MD System Chief of Cardiovascular Services, Main Line Health President, Lankenau Heart Institute Wynnewood, PA USA William A. Gray MD System Chief of Cardiovascular Services, President, Wynnewood, PA USA What are the possible causes of stroke in CAS? Operator error Technique (balloon sizing, wire misadventure, EPD

More information

CEA and cerebral protection Volodymyr labinskyy, MD

CEA and cerebral protection Volodymyr labinskyy, MD CEA and cerebral protection Volodymyr labinskyy, MD VA Hospital 7/26/2012 63 year old male presents for the vascular evaluation s/p TIA in January 2012 PMH: HTN, long term active smoker, Hep C PSH: None

More information

Management of cardiovascular disease - coronary interventions -

Management of cardiovascular disease - coronary interventions - Master Classes in Preventive Cardiology I Management of diabetes in patients with CVD European Heart House Management of cardiovascular disease - coronary interventions - Francesco Cosentino MD, PhD, FESC

More information